SyntekaBio Inc. - AI drug development service

Syntekabio: AI for Global Health

[SyntekaBio Inc. - AI drug development service @SyntekaBio]

STB Cloud for Global Health
Syntekabio's DeepMatcher fuels the engine at ABS Center, where disease barriers crumble and 100+ molecules at a time unlock new cures for a healthier future. Witness the power of AI-powered, disease-agnostic research in action with us! #AIDrugDiscovery

[SyntekaBio Inc. - AI drug development service @SyntekaBio]

Welcome to the Drug Discovery World, ABS Center!

#AIDrugDiscovery #DrugDiscovery #AI

[SyntekaBio Inc. - AI drug development service @SyntekaBio]

@SyntekaBio is excited to be attending BioInternational Convention in June.
Let us know if you'll be attending!
#aidrugdiscovery #biotechnology #pharmaceuticals

[SyntekaBio Inc. - AI drug development service @SyntekaBio]

Syntekabio to Showcase Biologics Discovery Platform at PEGS Boston next week!

https://t.co/m9uDnfa6TG

#AI #AIdrugdiscovery #Antibodydrug

[SyntekaBio Inc. - AI drug development service @SyntekaBio]

@Syntekabio will be showcasing our AI-based technology for NeoAntigenPrediction and Antibody Drug Discovery at the @PEGSummit in Boston, May 13-17, 2024.

Stop by our Booth #40 to learn more. See you there!

#PEGSummit #AI #BiologicDiscovery #AntibodyDrug #GeneTherapy

[SyntekaBio Inc. - AI drug development service @SyntekaBio]

@SyntekaBio to Showcase Innovative AI Drug Discovery Technologies at Bio-IT World:
Don’t make patients wait – offering solutions to rapidly bring novel drugs to IND-enabling stage

https://t.co/tfjzvD85oX

[SyntekaBio Inc. - AI drug development service @SyntekaBio]

What’s new in AI and supercomputing for drug discovery?

@Syntekabio will be attending the @Bioitworld Conference in Boston, Apr 15-17

Learn more about our AI-based development of small molecule drugs for 100+ targets covering 60-70% of major diseases, at Booth #22

#AI

[SyntekaBio Inc. - AI drug development service @SyntekaBio]

Welcome to the Drug Discovery World, ABS Center!

#AIDrugDiscovery #DrugDiscovery #AI

[SyntekaBio Inc. - AI drug development service @SyntekaBio]

We are going to open AI Bio Supercomputer Center in Daejeon with 10,000 units! A big leap in #AIDrugDiscovery, #Genomics, & #PersonalizedMedicine, driving progress in #GlobalHealth. Witness the future of #AI in #PharmaceuticalIndustry with @Syntekabio

https://t.co/gLNoF8C4nA

[SyntekaBio Inc. - AI drug development service @SyntekaBio]

Sadjad, business development scientist at Syntekabio, is attending the #BioFuture2023 conference in New York City to promote our full-cycle #DeepMatcher drug candidate service. Wishing him all the best and success!

[Sadjad Fakouri, PhD @sajfb0]

#AI is not the solution to all health industry problems, but the #DeepMatcher service of @SyntekaBio has shown to be effective AI-powered tool in small molecule #drug_discovery #BioFuture2023

[SyntekaBio Inc. - AI drug development service @SyntekaBio]

The #DeepMatcher service by @SyntekaBio is a pioneer in the #AI #drug_discovery field. DeepMatcher is equipped with modern deep learning techniques to fully optimize drug discovery and development.

[AtlanticLIVE @AtlanticLIVE]

Sponsor Content: @kchonyc of Genentech shares how much AI needs to progress in order to advance drug discovery. This session is produced by @genentech. #TAF23

[SyntekaBio Inc. - AI drug development service @SyntekaBio]

🔬 Exciting news! Syntekabio launched the Deepmatcher Drug Candidate service aiming to revolutionize the drug discovery process by cutting timelines to a few years and reducing costs by many folds! 💊👩‍🔬 #DrugDiscovery #PersonalizedMedicine #CloudComputing

https://t.co/lInpmNtsxg

[SyntekaBio Inc. - AI drug development service @SyntekaBio]

Unlocking AI-Driven Drug Discovery: Syntekabio's Supercomputing Approach https://t.co/r40VMPIjiY #biopharmatrend

[SyntekaBio Inc. - AI drug development service @SyntekaBio]

The Power of STB CLOUD in Remote AI Drug Development https://t.co/YFBvLbiU7M #biopharmatrend

[SyntekaBio Inc. - AI drug development service @SyntekaBio]

STB CLOUD, fully automated AI platform, designed for developers for easier and faster drug discovery. https://t.co/8K8Yl5Zxr0

[SyntekaBio Inc. - AI drug development service @SyntekaBio]

https://t.co/TsqqEYKA2E

[SyntekaBio Inc. - AI drug development service @SyntekaBio]

Hit Discovery Performance by DeepMatcher https://t.co/AnwFCMvetL via @YouTube

[SyntekaBio Inc. - AI drug development service @SyntekaBio]

Democratizing Early Drug Discovery through Artificial Intelligence: Interview with Syntekabio CEO Jongsun Jung https://t.co/8RXxtL2fED #biopharmatrend

[SyntekaBio Inc. - AI drug development service @SyntekaBio]

NYHF Webinar starts today 1/31/22 at 11:00AM, "2023 Trends in New Drug Development." Register now and join us from the link below. #biopharma #drugdevelopment #webinar

https://t.co/sKVdUnsAPl

[SyntekaBio Inc. - AI drug development service @SyntekaBio]

Participating Panelists.
~Hyun Joo, PhD | Principal Scientist/Director, @SyntekaBio
~Tae-Wan Kim, PhD | Associate Professor, @Columbia University
~Kern Chang, PhD | Scientific Integrator/Associate Director, @JanssenUS
~John Duguid, PhD | Managing Director, @auctusgroupinc

[SyntekaBio Inc. - AI drug development service @SyntekaBio]

Syntekabio's Principal Scientist/Director Hyun Joo, Ph.D. is among the invited panelists at NYHF to discuss the "2023 Trends in New #DrugDevelopment", January 31, 2023, 11:00 AM – 12:00 PM. Register at the link below to attend the #webinar!

https://t.co/nErnQAQL1m